Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human elafin

EU orphan designation number: EU/3/09/710   
Active ingredient: Recombinant human elafin
Indication: Treatment of oesophagus carcinoma
Sponsor: Proteo Biotech AG
Am Kiel Kanal 44, D-24106 Kiel, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/02/2010 Centralised Orphan - Designation EMEA/OD/057/09 (2010)656 of 28/01/2010